Abstract
In this mini review we discuss the interactions of polyaromatic hydrocarbons (PAHs) with graphene and the experimental approaches developed so far to create novel graphene/PAH hybrids and composite systems. The utilization of these systems in electrical, biomedical and polymer-reinforcement applications is described while special emphasis is given to environmental remediation issues.
Keywords: Graphene, graphene oxide, polycyclic aromatic hydrocarbons, non-covalent interactions, nanocomposites, polymer reinforcement, environmental remediation.
Graphical Abstract
Current Organic Chemistry
Title:Non-covalent Interactions of Graphene with Polycyclic Aromatic Hydrocarbons
Volume: 19 Issue: 18
Author(s): Panagiota Zygouri, Georgia Potsi, Eleftherios Mouzourakis, Konstantinos Spyrou, Dimitrios Gournis and Petra Rudolf
Affiliation:
Keywords: Graphene, graphene oxide, polycyclic aromatic hydrocarbons, non-covalent interactions, nanocomposites, polymer reinforcement, environmental remediation.
Abstract: In this mini review we discuss the interactions of polyaromatic hydrocarbons (PAHs) with graphene and the experimental approaches developed so far to create novel graphene/PAH hybrids and composite systems. The utilization of these systems in electrical, biomedical and polymer-reinforcement applications is described while special emphasis is given to environmental remediation issues.
Export Options
About this article
Cite this article as:
Zygouri Panagiota, Potsi Georgia, Mouzourakis Eleftherios, Spyrou Konstantinos, Gournis Dimitrios and Rudolf Petra, Non-covalent Interactions of Graphene with Polycyclic Aromatic Hydrocarbons, Current Organic Chemistry 2015; 19 (18) . https://dx.doi.org/10.2174/1385272819666150526003634
DOI https://dx.doi.org/10.2174/1385272819666150526003634 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genes that Modulate the Sensitivity for Anti-Microtubule Drug-Mediated Chemotherapy
Current Cancer Drug Targets Epigenetics: Relations to Disease and Laboratory Findings
Current Medicinal Chemistry <i>In Silico</i> Investigation: Opening Doors to Novel Thymidylate Synthase Inhibitors
Current Enzyme Inhibition Targeting the Most Upstream Site of Wnt Signaling Pathway Provides a Strategic Advantage for Therapy in Colorectal Cancer
Current Drug Targets Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours
Current Cancer Drug Targets Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets Editorial (Hot Topic: Development of New Molecular Agents Targeting Key Signalling Pathways Activated by Growth Factors in Human Cancer)
Current Pharmaceutical Design Antiangiogenesis in Myelodysplastic Syndrome
Current Cancer Drug Targets Implication of Aberrant Glycosylation in Cancer and Use of Lectin for Cancer Biomarker Discovery
Protein & Peptide Letters Isotyping the Human TOMM40 Variable-Length Polymorphism by Gene Amplification and Restriction Digest
Current Alzheimer Research Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors
Current HIV Research Ribozyme- and Deoxyribozyme-Strategies for Medical Applications
Current Drug Targets Molecular Modeling, Docking, Dynamics and Simulation of Gefitinib and its Derivatives with EGFR in Non-small Cell Lung Cancer
Current Computer-Aided Drug Design Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives
Current Cancer Drug Targets Gene Modified Cell Transplantation for Vascular Regeneration
Current Gene Therapy Policy and Health Implications of Using the U.S. Food and Drug Administration Product Design Approach in Reducing Tobacco Product Risk
Current Drug Abuse Reviews Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin
Current Pharmaceutical Biotechnology Immune Response Manipulation: Recombinant Immunoreceptors Endow T-Cells with Predefined Specificity
Current Pharmaceutical Design Influence of Biological and Technical Covariates on Non-targeted Metabolite Profiling in a Large-scale Epidemiological Study
Current Metabolomics